Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IPO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TTC17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZRANB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHTOP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPRS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POGLUT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SELK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTPCR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP3CA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL55 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LDLR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on